ASL Strategic Value Fund found inconsistencies in Avadel Pharmaceuticals' reported vote tallies.
2 reports, 1 independent
Updated Jul 14
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ASL Strategic Value Fund found inconsistencies in Avadel Pharmaceuticals' reported vote tallies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- A proxy battle has been launched concerning alleged missteps in the launch of the drug Lumryz.Sub-event
ASL Strategic Value Fund reported inconsistencies in Avadel's vote tallies.1 source
Keep exploring
The entities involved
-
Avadel Pharmaceuticals
specialty pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireASL Strategic Value Fund Issues Open Letter to Avadel Shareholders Urges Shareholders to Vote AGAINST All Director Nominees Amid Governance Failures and Calls for Independent Oversight of Annual Meet
- Unknown outlet